Betrixa40mg
Capsule
Square Pharmaceuticals Ltd.
Additional Offers
Show allIndication
Venous Thromboembolism Prevention
Administration
Take with food at approximately the same time each day
Adult Dose
Venous Thromboembolism Prevention Indicated for prophylaxis of venous thromboembolism (VTE) in adults hospitalized for acute medical illness who are at... View More
Renal Dose
Renal impairment Mild-to-moderate (CrCl >30 mL/min): No dose adjustment needed Severe (CrCl >15 to <30 mL/min): Initial single dose of 80 mg, then 4... View More
Contraindication
Active pathological bleeding Severe hypersensitivity
Mode of Action
Oral factor Xa (FXa) inhibitor that selectively blocks the active site of FXa and does not require a cofactor (eg, antithrombin III) for activity; inhib... View More
Precaution
Increases bleeding risk and can cause serious and potentially fatal bleeding; promptly evaluate any signs or symptoms of blood loss; there is no establi... View More
Side Effect
1-10% Clinically relevant nonmajor bleeding (2.45%) Epistaxis (2%) Hematuria (2%) <1% Bleeding Major bleeding (0.67%) GI bleeding (0.51%)... View More
Pregnancy Category Note
Pregnancy No data exist with use in pregnant women, but treatment is likely to increase risk of hemorrhage during pregnancy and delivery Use during ... View More
Interaction
Coadministration with drugs affecting hemostasis increases bleeding risk; examples include aspirin and other antiplatelet agents, other anticoagulants, ... View More
The information provided herein is accurate, updated and complete as per the best practices of the Company. Please note that this information should not... View More